During the past decade, Cuidados oncologicos conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Cuidados oncologicos" are "Non-Small Cell Lung Cancer" (2 trials), "HER2-Positive Early Breast Cancer" (1 trials), "Locally Advanced or Metastatic Breast Cancer" (1 trials) and "Non-small Cell Lung Cancer (NSCLC)" (1 trials). Many other conditions were trialed in "Cuidados oncologicos" in a lesser frequency.

Most popular intervention types in "Cuidados oncologicos" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (3 trials), "Tiragolumab" (2 trials), "Carboplatin" (1 trials), "Cisplatin" (1 trials) and "Docetaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cuidados oncologicos" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Cuidados oncologicos". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Cuidados oncologicos, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cuidados oncologicos, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".